Target intelligence / Profile preview

Ribosomal protein L31 pseudogene 39 (RPL31P39)

Target: RPL31P39
Molecular classification: Other, processed pseudogene

Overview

Ribosomal protein L31 pseudogene 39 (RPL31P39) is a processed pseudogene in the human genome, derived from the ribosomal protein L31 gene family. It does not code for a functional protein and has no known physiological or pathological role. This designation is mostly a genomic annotation, indicating sequence similarity to the parent gene RPL31, but lacking protein-coding capacity or biological function. The human genome contains many processed pseudogenes of ribosomal protein genes generated by retrotransposition processes, which do not produce functional proteins and are not therapeutic targets[5][7].

Other names: RPL31_11_842RPL31P39

Mechanism of action

None

Biological functions

None

Disease associations

None

Beyond the preview

Go deeper on Ribosomal protein L31 pseudogene 39 (RPL31P39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L31 pseudogene 39 (RPL31P39).

Explore the full profile